🇩🇪 Germany Country × Condition
obesity Clinical Trials in Germany
Active clinical trials for obesity with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇩🇪 Germany
Active Trials in Germany (3)
NCT07508020 Phase 1
Recruiting
A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After Meals in People With Obesity
Enrollment
120 pts
Country
🇩🇪 Germany
Novo Nordisk A/S
View Trial → NCT07702890 Phase 1, Phase 2
Recruiting
A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D
Enrollment
188 pts
Country
🇩🇪 Germany
Gubra A/S
View Trial → NCT07743450 Phase 3
Recruiting
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Enrollment
1,560 pts
Country
🇩🇪 Germany
Ascletis Pharma (China) Co., Limite...
View Trial → Frequently Asked Questions
How many obesity clinical trials are active in Germany?
There are currently 3 active clinical trials for obesity with sites in Germany, of which 3 are actively recruiting patients.
How can I join a obesity clinical trial in Germany?
To join a obesity clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are obesity trials in Germany?
Active obesity trials in Germany span Phase 1, Phase 1, Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology